Related Experiment Videos
Modification of cellular communication by gene transfer.
J Kevin Donahue1, Alexander Bauer, Kan Kikuchi
1Institute of Molecular Cardiobiology and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. kdonahue@jhmi.edu
Annals of the New York Academy of Sciences
|August 12, 2005
Summary
Gene therapy offers potential for treating cardiovascular diseases by improving cellular communication. Overcoming current challenges could make gene therapy a viable clinical option for cardiac conditions.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Biotechnology
Background:
- Cardiovascular diseases remain a leading cause of morbidity and mortality.
- Gene and cell therapies show promise but face significant translational challenges.
- Understanding cellular communication is key to developing novel cardiac treatments.
Purpose of the Study:
- To review the potential of gene therapy in modulating cardiovascular cellular communication.
- To explore gene therapy's effects on transcellular and intracellular cardiac processes.
- To identify and discuss challenges hindering clinical application of cardiac gene therapy.
Main Methods:
- Literature review focusing on gene therapy applications in cardiovascular research.
- Analysis of studies investigating gene therapy's impact on angiogenesis, AV nodal conduction, sinus nodal automaticity, and myocyte repolarization.
- Examination of obstacles in the bench-to-bedside translation of gene therapy.
Main Results:
- Gene therapy can influence transcellular communication, affecting angiogenesis and cardiac electrical conduction (AV and sinus nodes).
- Intracellular effects include modulation of cardiac myocyte repolarization.
- Significant challenges remain in vector biology and physiological understanding.
Conclusions:
- Gene therapy holds real potential for the treatment or cure of cardiac disease.
- Addressing current challenges in gene therapy is crucial for clinical viability.
- Further research into physiology and vector biology will advance cardiac gene therapy.